Chips

Onto Innovation's record quarter hides a $40.8 million Tokyo mark

The rally quoted adjusted earnings of $2.44 a share; the same-day filing reports GAAP EPS of $0.95, and the gap carries a $40.8 million mark on Onto's own $720 million Rigaku check that will recur every quarter.

Vincent JiangVincent Jiangtwo-minute read
Share
A Rigaku SmartLab X-ray diffractometer, an instrument made by the Japanese X-ray metrology company in which Onto Innovation bought a 27% stake
1 / 6Slide 1 of 6
A Rigaku SmartLab X-ray diffractometer. Onto Innovation paid $720 million in August for a 27% stake in Rigaku, whose falling share price cost Onto a $40.8 million unrealized loss in the September quarter.

Onto Innovation+2.31% — Onto Innovation, up 2.31 percent as of its last quote printed a record quarter on November 9 and the market cheered it: revenue of $409.7 million, up 87.8% year over year, backlog up 20% to more than $1.3 billion, and fourth-quarter guidance of $430 million to $450 million 13. The stock closed up 11.98% at $194.04 and rose another 7.5% pre-market 2. The rally quoted adjusted earnings of $2.44 a share 1. The filing that same evening reports GAAP diluted earnings of $0.95 1.

The gap is a Tokyo stock

The difference is one line item plus its bookkeeping. In August, Onto paid $720 million for a 27% stake in Rigaku, a Japanese X-ray metrology company 12. By September 30 Rigaku's shares had fallen to JPY 1,740, and Onto booked a $40.8 million unrealized loss through other income, about JPY 120 per Onto share held 12.

The 8-K's reconciliation table shows the adjustments that carry reported earnings of $0.95 to adjusted earnings of $2.44 total $1.49 per share, including $0.97 of merger and acquisition related expenses, where the Rigaku mark sits 1. Keep the mark, and $0.95 is what the ledger says 1.

CFO Brian Roberts told analysts Onto will re-mark the stake every quarter against Rigaku's share price, in GAAP results only; the adjusted number excludes it 24. From here, Onto's GAAP profit moves with a Tokyo price it does not control.

The cash floor also moved

The Rigaku check redrew the balance sheet. Onto ended September with $1.25 billion of cash and marketable securities after the payment and roughly $80 million of quarterly free cash flow, but it now carries $1.47 billion of 2031 notes 15. Before August that was about $400 million of net cash; after, roughly $220 million of net debt 15. Nothing is distressed, but the cushion trading as "cash on hand" is partly borrowed.

What holds at $194

None of this touches the operating story. Gross margin reached 57.6% and operating margin 32.6%, advanced packaging revenue is on track to grow over 80% this year, and management guides sequential growth through at least the first half of 2027 25.

Price both numbers

CEO Mike Plisinski also said no customer has slowed orders despite data-center spending jitters 2. A buyer at these levels is purchasing two different numbers. The backlog converts to revenue on Onto's schedule; Rigaku re-marks on Tokyo's. Price both.

Onto's revenue has climbed for six straight quarters into a $430-450M guide

Six straight quarters of growth, with guidance pointing to a seventh

  • Estimate
$0M$100M$200M$300M$400M$500MQ1 '25$267MQ2 '25$254MQ3 '25$218.2MQ4 '25*$267MQ1 '26$292MQ2 '26$343.1MQ3 '26$409.7MQ4 '26 guide$430–450M
Data
ValueRange
Q1 '25$267M—
Q2 '25$254M—
Q3 '25$218.2M—
Q4 '25*$267M—
Q1 '26$292M—
Q2 '26$343.1M—
Q3 '26$409.7M—
Q4 '26 guide (estimate)$450M$430–450M
Quarterly revenue, $ millions. Q4 2025 derived from fiscal-year figures; Q4 2026 shown at the top of the company's $430-450M guidance range. Sources: Onto Innovation 8-K Exhibit 99.1 (Nov 9, 2026); Chip Dispatch quarter series.1,3

Get Chips by email, free

How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.

Loading ONTO

Reader comments

0 comments

    Chips

    Nvidia fell 4.3%, erasing $190 billion; Warren's chip export bill nears the defense bill

    Three bipartisan export-control bills are racing toward the must-pass defense bill in weeks, replacing the White House's flexible posture on Nvidia's China sales with statute. Nvidia shareholders own whatever the law does to a market Washington used to ration by deal.

    Chips

    Infineon ties its €3-3.5 billion chip buildout to customer commitments, and Vertiv signed first

    Europe's largest chipmaker booked a record €16.35 billion year and guided fiscal 2027 to €20 billion, yet will not spend €3-3.5 billion on capacity until buyers commit. Its near-€4 billion data-center bet hangs on signatures, and this week Vertiv gave the first one.

    Chips

    SMIC's record quarter hides a 17% profit drop from Q2

    Thursday's print will be billed as a profit doubling, but the same consensus number is 17% below Q2, because last quarter's headline carried a quarter-billion of investment gains. The money is in the gross-margin guide, the Q4 outlook and a depreciation bill running above $1.2 billion a quarter.

    Chips

    AMD's $8.2 billion World Labs buy rests on a 19-model win World Labs' CEO claims, with no paper

    The first-place result was posted by World Labs' own CEO, with no paper, model card or code behind it, and AMD's 10-Q of November 4 still lists the $8.2 billion stock purchase as pending. The rival keynote at this week's robot-learning conference brings robots that have worked a Toyota plant since February.

    Chips

    Murata commits about $6.7 billion to capacitor capacity while warning some orders may have been pulled forward

    Murata's trillion-yen capacitor build-out rests on a record order book its own presentation warns may include orders brought forward. Which reading is right decides whether holders paying about 31 times earnings own a step-change or a pull-forward.

    Chips

    Sequans sold its last bitcoin for $24.6 million; its $37.5 million cap sits under NYSE's $50 million floor

    The IoT chipmaker's crypto treasury chapter is closed, and the $39.7 million it freed now rides on Iris RF shipments to a drone customer this quarter, with the stock sitting under the NYSE listing floor and the cure clock running.

    Get the newsletter

    The day's AI and market news, in your inbox every weekday.